<DOC>
	<DOC>NCT00546182</DOC>
	<brief_summary>We hypothesized simvastatin may reduce adiponectin levels and insulin sensitivity in overweight hypercholesterolemic patients.</brief_summary>
	<brief_title>Simvastatin Reduces Adiponectin Levels and Insulin Sensitivity</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Lowdensity lipoprotein cholesterol levels more than 100 and body mass index more than 23.0 Patients with overt liver disease Chronic renal failure Hypothyroidism, myopathy Uncontrolled diabetes Severe hypertension, stroke Acute coronary events Coronary revascularization within the preceding 3 months, or Alcohol abuse.</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Lipophilic statins</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>hypercholesterolemic patients</keyword>
</DOC>